Sophia Gayle is a biologist specializing in early drug development and biomarker discovery. Sophia trained in Tian Xu’s laboratory at Yale University in the development and application of novel forward-genetics technologies in human embryonic stem cells. After her PhD, she worked in the field of drug repurposing for oncology and rare disease indications. Sophia joined Cybrexa in January of 2019 and leads both in vitro and in vivo biology teams.